Lyfgenia (lovo-cel), a lentiviral gene therapy, led to complete resolution of vaso-occlusive events in 28 of 32 patients
This makes them ideal for individuals with trouble absorbing Vitamin B12 orally, such as those with gastrointestinal issues like Crohns disease or pernicious anemia
The pioneering 2017 Phase 1b trial of setmelanotide (mentioned above), while providing a critical proof-of-concept for weight loss in a small cohort of heterozygous carriers, was primarily designed as an exploratory study
The package supports a variety of effect measures, including the odds ratio, risk ratio, risk difference, mean difference, and standardized mean difference
A recent Morgan Stanley analysis predicts GLP-1s will reduce the consumption of sodas, baked goods and salty snacks by up to 3% in the next decade
(Some are.) There may be some wiggle room, though